Loading...

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

BACKGROUND AND AIMS: Teduglutide, a GLP-2 analogue, may restore intestinal structural and functional integrity by promoting repair and growth of the mucosa and reducing gastric emptying and secretion, thereby increasing fluid and nutrient absorption in patients with short bowel syndrome (SBS). This...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Jeppesen, P B, Gilroy, R, Pertkiewicz, M, Allard, J P, Messing, B, O'Keefe, S J
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Group 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3112364/
https://ncbi.nlm.nih.gov/pubmed/21317170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2010.218271
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!